Yup agreed, the results aren't disappointing but unfortunately the market's reaction to this is most likely going to be devastating, having experienced this myself in another biotech last year. Worst case, hope stop losses can stem the bleeding, best case, hope the market sees that there is potential (and jumps) based on the second endpoint they highlight:
Ann: Preliminary SIRFLOX Study Results, page-6
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $65.79M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.3¢ | $395.4K | 2.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 2728183 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 84474 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |